C6-ceramide nanoliposome suppresses tumor metastasis by eliciting PI3K and PKCζ tumor-suppressive activities and regulating integrin affinity modulation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Pu ^a,b   Fu, Changliang ^b   Hu, Yijuan ^c   Dong, Cheng ^b   Song, Yang ^a   Song, Erqun ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; INTEGRIN; LIPOSOME; NANOMATERIAL; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN KINASE C ZETA;

HUMAN; METABOLISM; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTEIN TRANSPORT; TUMOR CELL LINE;

CELL LINE, TUMOR; CERAMIDES; HUMANS; INTEGRINS; LIPOSOMES; NANOSTRUCTURES; NEOPLASM METASTASIS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN TRANSPORT;

EID: 84925434998     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09275     Document Type: Article

References (58)

1. Reynolds, C. P., Maurer, B. J. & Kolesnick, R. N. Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Letters 206, 169-180, doi:DOI 10.1016/j.canlet.2003.08.034 (2004).
2. Stover, T. & Kester, M. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 307, 468-475, doi:10.1124/jpet.103.054056 (2003).
3. Fox, T. E. et al. Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains. J Biol Chem 282, 12450-12457, doi:10.1074/jbc.M700082200 (2007).
4. Tagaram, H. R. et al. Nanoliposomal ceramide prevents in vivo growth of hepatocellular carcinoma. Gut 60, 695-701, doi:10.1136/gut.2010.216671 (2011).
5. Ryland, L. K. et al. C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia. PLoS One 8, e84648, doi:10.1371/journal.pone.0084648 (2013).
6. Tran, M. A., Smith, C. D., Kester, M. & Robertson, G. P. Combining nanoliposomal ceramide with sorafenib synergistically inhibits melanoma and breast cancer cell survival to decrease tumor development. Clin Cancer Res 14, 3571-3581, doi:10.1158/1078-0432.CCR-07-4881 (2008).
7. Jiang, Y. et al. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Cancer Biol Ther 12, 574-585 (2011).
8. Slattery, M. J. & Dong, C. Neutrophils influence melanoma adhesion and migration under flow conditions. Int J Cancer 106, 713-722, doi:10.1002/ijc.11297 (2003).
9. Wirtz, D., Konstantopoulos, K. & Searson, P. C. The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11, 512-522, doi:10.1038/nrc3080 (2011).
10. Steinberg, S. F. Structural basis of protein kinase C isoform function. Physiol Rev 88, 1341-1378, doi:10.1152/physrev.00034.2007 (2008).
11. Newton, A. C. Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 298, E395-402, doi:10.1152/ajpendo.00477.2009 (2010).
12. Hirai, T. & Chida, K. Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J Biochem 133, 1-7 (2003).
13. Huang, S. et al . HGF-induced PKCzeta activation increases functional CXCR4 expression in human breast cancer cells. PLoS One 7, e29124, doi:10.1371/journal.pone.0029124 (2012).
14. Konstantopoulos, K. & Thomas, S. N. Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 11, 177-202, doi:10.1146/annurev-bioeng-061008-124949 (2009).
15. Thomas, S. N., Zhu, F., Schnaar, R. L., Alves, C. S. & Konstantopoulos, K. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 283, 15647-15655, doi:10.1074/jbc.M800543200 (2008).
16. Liang, S., Slattery, M. J. & Dong, C. Shear stress and shear rate differentially affect the multi-step process of leukocyte-facilitated melanoma adhesion. Exp Cell Res 310, 282-292, doi:10.1016/j.yexcr.2005.07.028 (2005).
17. Zhang, P., Ozdemir, T., Chung, C. Y., Robertson, G. P. & Dong, C. Sequential binding of alphaVbeta3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils. J Immunol 186, 242-254, doi:10.4049/jimmunol.1000494 (2011).
18. Ozdemir, T., Zhang, P., Fu, C. & Dong, C. Fibrin serves as a divalent ligand that regulates neutrophil-mediated melanoma cells adhesion to endothelium under shear conditions. Am J Physiol Cell Physiol 302, C1189-1201, doi:10.1152/ajpcell.00346.2011 (2012).
19. Huh, S. J., Liang, S., Sharma, A., Dong, C. & Robertson, G. P. Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development. Cancer Res 70, 6071-6082, doi:10.1158/0008-5472.CAN-09-4442 (2010).
20. Liang, S., Slattery, M. J., Wagner, D., Simon, S. I. & Dong, C.Hydrodynamic shear rate regulates melanoma-leukocyte aggregation, melanoma adhesion to the endothelium, and subsequent extravasation. Ann Biomed Eng 36, 661-671, doi:10.1007/s10439-008-9445-8 (2008).
21. Liang, S., Sharma, A., Peng, H. H., Robertson, G. & Dong, C. Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation. Cancer Res 67, 5814-5820, doi:10.1158/0008-5472.CAN-06-4233 (2007).
22. Zhao, Y. et al. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 67, 5821-5830, doi:10.1158/0008-5472.CAN-06-4499 (2007).
23. Taherian, A., Li, X., Liu, Y. & Haas, T. A. Differences in integrin expression and signaling within human breast cancer cells. BMC Cancer 11, 293, doi:10.1186/1471-2407-11-293 (2011).
24. Gomes, N. et al. Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: effects of alphavbeta3 and alphaIIbbeta3 antagonists. Clin Exp Metastasis 21, 553-561 (2004).
25. Felding-Habermann, B. et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A 98, 1853-1858, doi:10.1073/pnas.98.4.1853 (2001).
26. Feldinghabermann, B., Ruggeri, Z. M. & Cheresh, D. A. Distinct Biological Consequences of Integrin-Alpha-V-Beta-3-Mediated Melanoma Cell-Adhesion to Fibrinogen and Its Plasmic Fragments. Journal of Biological Chemistry 267, 5070-5077 (1992).
27. Ryland, L. K., Fox, T. E., Liu, X., Loughran, T. P. & Kester, M. Dysregulation of sphingolipid metabolism in cancer. Cancer Biol Ther 11, 138-149 (2011).
28. Hodgson, L., Henderson, A. J. & Dong, C. Melanoma cell migration to type IV collagen requires activation of NF-kappaB. Oncogene 22, 98-108, doi:10.1038/sj.onc.1206059 (2003).
29. Slattery, M. J., Liang, S. & Dong, C. Distinct role of hydrodynamic shear in leukocyte-facilitated tumor cell extravasation. Am J Physiol Cell Physiol 288, C831-839, doi:10.1152/ajpcell.00439.2004 (2005).
30. Liang, S.&Dong, C. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions. Am J Physiol Cell Physiol 295, C701-707, doi:10.1152/ajpcell.00245.2008 (2008).
31. Alon, R. & Ley, K. Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol 20, 525-532, doi:10.1016/j.ceb.2008.04.003 (2008).
32. Morad, S. A. & Cabot, M. C. Ceramide-orchestrated signalling in cancer cells. Nat Rev Cancer 13, 51-65, doi:10.1038/nrc3398 (2013).
33. Urtreger, A. J., Kazanietz, M. G. & Bal de Kier Joffe, E. D. Contribution of individual PKC isoforms to breast cancer progression. IUBMB Life 64, 18-26, doi:10.1002/iub.574 (2012).
34. Griner, E. M. & Kazanietz, M. G. Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7, 281-294, doi:10.1038/nrc2110 (2007).
35. Cenni, V. et al. Regulation of novel protein kinase C epsilon by phosphorylation. Biochem J 363, 537-545 (2002).
36. Reis, C. et al. A role for PKCzeta in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin. Mol Cancer Ther 4, 1457-1464, doi:10.1158/1535-7163.MCT-05-0156 (2005).
37. Luo, B. H., Carman, C. V. & Springer, T. A. Structural basis of integrin regulation and signaling. Annu Rev Immunol 25, 619-647, doi:10.1146/annurev.immunol.25.022106.141618 (2007).
38. Leitinger, B., McDowall, A., Stanley, P. & Hogg, N. The regulation of integrin function by Ca(2+). Biochim Biophys Acta 1498, 91-98 (2000).
39. Park, S. S. et al. C(16)-Ceramide-induced F-actin regulation stimulates mouse embryonic stem cell migration: involvement of N-WASP/Cdc42/Arp2/3 complex and cofilin-1/alpha-actinin. Biochim Biophys Acta 1831, 350-360, doi:10.1016/j.bbalip.2012.09.005 (2013).
40. Wang, F., Van Brocklyn, J. R., Edsall, L., Nava, V. E. & Spiegel, S. Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors. Cancer Res 59, 6185-6191 (1999).
41. Debret, R. et al. Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation. Biochim Biophys Acta 1783, 1718-1727, doi:10.1016/j.bbamcr.2008.06.001 (2008).
42. Signorelli, P., Luberto, C. & Hannun, Y. A. Ceramide inhibition of NF-kappaB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl-terminal phosphorylation of PKC for the ceramide response. FASEB J 15, 2401-2414, doi:10.1096/fj.01-0244com (2001).
43. Mostafavi-Pour, Z. et al . Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J Cell Biol 161, 155-167, doi:10.1083/jcb.200210176 (2003).
44. Sun, R. et al. Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells. Cancer Res 65, 1433-1441, doi:10.1158/0008-5472.CAN-04-1163 (2005).
45. Laudanna, C., Mochly-Rosen, D., Liron, T., Constantin, G. & Butcher, E. C. Evidence of zeta protein kinase C involvement in polymorphonuclear neutrophil integrin-dependent adhesion and chemotaxis. J Biol Chem 273, 30306-30315 (1998).
46. Petit, I. et al. Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells. J Clin Invest 115, 168-176, doi:10.1172/JCI21773 (2005).
47. Liu, P., Cheng, H., Roberts, T. M. & Zhao, J. J. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 8, 627-644, doi:10.1038/nrd2926 (2009).
48. Metzner, B., Barbisch, M., Bachmann, F., Czech, W.&Norgauer, J. Evidence of the involvement of phosphatidylinositol 3-kinase in the migration, actin stress fiber formation, and alpha v beta 3-integrin-mediated adherence of human melanoma cells. J Invest Dermatol 107, 597-602 (1996).
49. Ridley, A. J. et al. Cell migration: integrating signals from front to back. Science 302, 1704-1709, doi:10.1126/science.1092053 (2003).
50. Brown, M. C. & Turner, C. E. Paxillin: adapting to change. Physiol Rev 84, 1315-1339, doi:10.1152/physrev.00002.2004 (2004).
51. Mitra, S. K., Hanson, D. A.&Schlaepfer, D. D. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6, 56-68, doi:10.1038/nrm1549 (2005).
52. Webb, D. J. et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 6, 154-161, doi:10.1038/ncb1094 (2004).
53. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314 (1994).
54. Chen, S., Alon, R., Fuhlbrigge, R. C. & Springer, T. A. Rolling and transient tethering of leukocytes on antibodies reveal specializations of selectins. Proc Natl Acad Sci U S A 94, 3172-3177 (1997).
55. Alon, R., Hammer, D. A. &Springer, T. A. Lifetime of the P-selectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature 374, 539-542, doi:10.1038/374539a0 (1995).
56. Askari, J. A., Buckley, P. A., Mould, A. P. & Humphries, M. J. Linking integrin conformation to function. J Cell Sci 122, 165-170, doi:10.1242/jcs.018556 (2009).
57. Rolli, M., Fransvea, E., Pilch, J., Saven, A. & Felding-Habermann, B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc Natl Acad Sci U S A 100, 9482-9487, doi:10.1073/pnas.1633689100 (2003).
58. Fu, C. et al. Determining beta2-integrin and intercellular adhesion molecule 1 binding kinetics in tumor cell adhesion to leukocytes and endothelial cells by a gas-driven micropipette assay. J Biol Chem 286, 34777-34787, doi:10.1074/jbc.M111.281642 (2011).